NASDAQ: COEPCoeptis Therapeutics Holdings Inc Stock Ownership - Who owns Coeptis Therapeutics Holdings?
Insider buying vs selling
Have Coeptis Therapeutics Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Tara Desilva | Director | 2024-01-12 | 466 | $0.56 | $260.96Buy |
| Tara Desilva | Director | 2024-01-12 | 1,800 | $0.58 | $1.04kBuy |
| Brian Cogley | Chief Financial Officer | 2024-01-10 | 5,000 | $0.67 | $3.35kBuy |
| David Mehalick | CEO and President | 2024-01-08 | 14,004 | $0.66 | $9.24kBuy |
| David Mehalick | CEO and President | 2024-01-08 | 6,000 | $0.67 | $4.02kBuy |
| Daniel Alexander Yerace | VP of Operations | 2024-01-05 | 10,850 | $0.69 | $7.49kBuy |
| David Mehalick | CEO and President | 2024-01-05 | 5,050 | $0.69 | $3.48kBuy |
| Gene Salkind | Director | 2024-01-05 | 11,600 | $0.69 | $8.00kBuy |
| Christopher P. Cochran | Director | 2024-01-05 | 7,000 | $0.77 | $5.39kBuy |
COEP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when COEP insiders and whales buy or sell their stock.
COEP Shareholders
What type of owners hold Coeptis Therapeutics Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Chris Calise | 8.41% | 3,339,897 | $617.88k | Insider |
| David Mehalick | 7.01% | 2,782,615 | $514.78k | Insider |
| Robert Striar | 4.72% | 1,875,000 | $346.88k | Insider |
| Bull Horn Holdings Sponsor LLC | 4.72% | 1,875,000 | $346.88k | Insider |
| Daniel Alexander Yerace | 2.70% | 1,071,455 | $198.22k | Insider |
| Christine Elise Sheehy | 2.54% | 1,010,605 | $186.96k | Insider |
| Barclays PLC | 2.47% | 979,975 | $181.30k | Insider |
| Glazer Capital LLC | 2.43% | 964,422 | $178.42k | Insider |
| Creative Planning | 1.62% | 645,104 | $119.34k | Institution |
| Harraden Circle Investments LLC | 1.30% | 514,436 | $95.17k | Insider |
COEP vs Biotech Stocks
Coeptis Therapeutics Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.